Kota Sunil, Jammula Sruti, Kota Siva, Meher Lalit, Modi Kirtikumar
Department of Endocrinology, Medwin Hospital, Hyderabad, Andhra Pradesh, India.
Indian J Orthop. 2013 Jul;47(4):402-7. doi: 10.4103/0019-5413.114932.
Bone mineral densiy (BMD) is known to be affected by serum 25-hydroxyvitamin D (25(OH) D) levels, intact parathyroid hormone (iPTH) levels. Indian data pertinent to above observation is scant. Our study aimed to investigate the relationships between serum 25-hydroxyvitamin D (25(OH) D) levels, intact parathyroid hormone (iPTH) levels and bone mineral density (BMD) in a cohort of Indian patients.
Adults with or without fragility fractures with low BMD at the hip or lumbar spine were evaluated clinically along with laboratory investigations. T-scores of the hip and spine were derived from BMD-DEXA (dual-energy X-ray absorptiometry). Multivariate regression models were used to investigate the relationships between serum 25(OH) D, iPTH and BMD.
Total of 102 patients (male:female = 38:64) with a mean age of 62.5 ± 6.4 years were included in the study. Forty-four patients had osteopenia. Osteoporosis was present in 58 patients. The mean values for serum 25(OH) D and iPTH levels were 21.3 ± 0.5 ng/ml and 53.1 ± 22.3 pg/ml, respectively. In 84.3% of patients, serum 25(OH) D levels were below 30 ng/ml (Normal = 30-74 ng/ml), confirming vitamin D deficiency. There was no association between 25(OH) D levels and BMD at the hip or lumbar spine (P = 0.473 and 0.353, respectively). Both at the hip and lumbar spine; iPTH levels, male gender, body mass index (BMI) and age were found to be significant predictors of BMD. Patients with higher BMI had significantly lower BMD and T-score. At levels <30 ng/ml, 25(OH) D was negatively associated with iPTH (P = 0.041).
Among our cohort of patients with low BMD, no direct relationship between serum 25(OH) D levels and BMD was observed. However, a negative correlation between iPTH and 25(OH) D at serum 25(OH) D concentrations <30 ng/ml. Serum iPTH levels showed a significant negative association with BMD at the hip and lumbar spine. Our findings underscore the critical role of parathyroid hormone in bone metabolism and health.
已知骨矿物质密度(BMD)受血清25-羟基维生素D(25(OH)D)水平、全段甲状旁腺激素(iPTH)水平影响。与上述观察结果相关的印度数据很少。我们的研究旨在调查一组印度患者的血清25-羟基维生素D(25(OH)D)水平、全段甲状旁腺激素(iPTH)水平与骨矿物质密度(BMD)之间的关系。
对有或无脆性骨折、髋部或腰椎骨密度低的成年人进行临床评估及实验室检查。髋部和脊柱的T值由骨密度双能X线吸收法(BMD-DEXA)得出。采用多变量回归模型研究血清25(OH)D、iPTH与BMD之间的关系。
本研究共纳入102例患者(男:女 = 38:64),平均年龄62.5±6.4岁。44例患者有骨量减少。58例患者患有骨质疏松症。血清25(OH)D和iPTH水平的平均值分别为21.3±0.5 ng/ml和53.1±22.3 pg/ml。84.3%的患者血清25(OH)D水平低于30 ng/ml(正常范围 = 30 - 74 ng/ml),证实存在维生素D缺乏。25(OH)D水平与髋部或腰椎的骨密度之间无关联(P值分别为0.473和0.353)。在髋部和腰椎,iPTH水平、男性性别、体重指数(BMI)和年龄均是骨密度的显著预测因素。BMI较高的患者骨密度和T值显著较低。在25(OH)D水平<30 ng/ml时,25(OH)D与iPTH呈负相关(P = 0.041)。
在我们这组骨密度低的患者中,未观察到血清25(OH)D水平与骨密度之间有直接关系。然而,在血清25(OH)D浓度<30 ng/ml时,iPTH与25(OH)D呈负相关。血清iPTH水平与髋部和腰椎的骨密度呈显著负相关。我们的研究结果强调了甲状旁腺激素在骨代谢和健康中的关键作用。